Works matching AU Lode, Holger

Results: 63
    1

    Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells.

    Published in:
    Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-05006-1
    By:
    • Riess, Christin;
    • del Moral, Katharina;
    • Fiebig, Adina;
    • Kaps, Philipp;
    • Linke, Charlotte;
    • Hinz, Burkhard;
    • Rupprecht, Anne;
    • Frank, Marcus;
    • Fiedler, Tomas;
    • Koczan, Dirk;
    • Troschke-Meurer, Sascha;
    • Lode, Holger N.;
    • Engel, Nadja;
    • Freitag, Thomas;
    • Classen, Carl Friedrich;
    • Maletzki, Claudia
    Publication type:
    Article
    2
    3

    Mucoepidermoid carcinoma of the lung in a 6-year-old boy.

    Published in:
    African Journal of Paediatric Surgery, 2012, v. 9, n. 2, p. 159, doi. 10.4103/0189-6725.99406
    By:
    • Wildbrett, Peer;
    • Horras, Nikolaus;
    • Lode, Holger;
    • Warzok, Rolf;
    • Heidecke, Claus-Dieter;
    • Barthlen, Winfried
    Publication type:
    Article
    4
    5
    6
    7

    Mutational dynamics between primary and relapse neuroblastomas.

    Published in:
    Nature Genetics, 2015, v. 47, n. 8, p. 872, doi. 10.1038/ng.3349
    By:
    • Schramm, Alexander;
    • Althoff, Kristina;
    • Mahlow, Ellen;
    • Odersky, Andrea;
    • Henssen, Anton G;
    • Stephan, Harald;
    • De Preter, Katleen;
    • Speleman, Frank;
    • Plass, Christoph;
    • Lee, Sangkyun;
    • Lode, Holger N;
    • Henrich, Kai-Oliver;
    • Gartlgruber, Moritz;
    • Westermann, Frank;
    • Rahmann, Sven;
    • Fischer, Matthias;
    • Eggert, Angelika;
    • Schulte, Johannes H;
    • Köster, Johannes;
    • Beisser, Daniela
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD<sub>2</sub> Coated Nanoparticles.

    Published in:
    PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0038129
    By:
    • Tivnan, Amanda;
    • Orr, Wayne Shannon;
    • Gubala, Vladimir;
    • Nooney, Robert;
    • Williams, David E.;
    • McDonagh, Colette;
    • Prenter, Suzanne;
    • Harvey, Harry;
    • Domingo-Fernández, Raquel;
    • Bray, Isabella M.;
    • Piskareva, Olga;
    • Ng, Catherine Y.;
    • Lode, Holger N.;
    • Davidoff, Andrew M.;
    • Stallings, Raymond L.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD 2 antibody ch14.18/CHO.

    Published in:
    mAbs (1942-0862), 2018, v. 10, n. 1, p. 55, doi. 10.1080/19420862.2017.1402997
    By:
    • Mueller, Ina;
    • Ehlert, Karoline;
    • Endres, Stefanie;
    • Pill, Lena;
    • Siebert, Nikolai;
    • Kietz, Silke;
    • Brock, Penelope;
    • Garaventa, Alberto;
    • Valteau-Couanet, Dominique;
    • Janzek, Evelyne;
    • Hosten, Norbert;
    • Zinke, Andreas;
    • Barthlen, Winfried;
    • Varol, Emine;
    • Loibner, Hans;
    • Ladenstein, Ruth;
    • Lode, Holger N.
    Publication type:
    Article
    22
    23
    24
    25
    26

    Targeting of heme oxygenase-1 as a novel immune regulator of neuroblastoma.

    Published in:
    International Journal of Cancer, 2016, v. 138, n. 8, p. 2030, doi. 10.1002/ijc.29933
    By:
    • Fest, Stefan;
    • Soldati, Rocio;
    • Christiansen, Nina M.;
    • Zenclussen, Maria L.;
    • Kilz, Jana;
    • Berger, Elisa;
    • Starke, Sven;
    • Lode, Holger N.;
    • Engel, Christoph;
    • Zenclussen, Ana C.;
    • Christiansen, Holger
    Publication type:
    Article
    27
    28

    Survivin minigene DNA vaccination is effective against neuroblastoma.

    Published in:
    International Journal of Cancer, 2009, v. 125, n. 1, p. 104, doi. 10.1002/ijc.24291
    By:
    • Fest, Stefan;
    • Huebener, Nicole;
    • Bleeke, Matthias;
    • Durmus, Tahir;
    • Stermann, Alexander;
    • Woehler, Anja;
    • Baykan, Bianca;
    • Zenclussen, Ana C.;
    • Michalsky, Elke;
    • Jaeger, Ines S.;
    • Preissner, Robert;
    • Hohn, Oliver;
    • Weixler, Silke;
    • Gaedicke, Gerhard;
    • Lode, Holger N.
    Publication type:
    Article
    29

    NK cells engineered to express a GD<sub>2</sub>-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.

    Published in:
    Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 3, p. 569, doi. 10.1111/j.1582-4934.2011.01343.x
    By:
    • Esser, Ruth;
    • Müller, Tina;
    • Stefes, Dörthe;
    • Kloess, Stephan;
    • Seidel, Diana;
    • Gillies, Stephen D.;
    • Aperlo-Iffland, Christel;
    • Huston, James S.;
    • Uherek, Christoph;
    • Schönfeld, Kurt;
    • Tonn, Torsten;
    • Huebener, Nicole;
    • Lode, Holger N.;
    • Koehl, Ulrike;
    • Wels, Winfried S.
    Publication type:
    Article
    30
    31
    32
    33
    34

    Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study—the COVIDKID study.

    Published in:
    PeerJ, 2024, p. 1, doi. 10.7717/peerj.18384
    By:
    • Vollmer, Marcus;
    • Kuthning, Daniela;
    • Gramenz, Jana;
    • Scholz, Arevik;
    • Michael, Robin;
    • Wittmann, Nico;
    • Gesser, Udo;
    • Niesytto, Christian;
    • Vogler, Antje;
    • Tuxhorn, Vanda;
    • Lenschow, Ute;
    • Lange, Anja;
    • Linnemann, Kristina;
    • Lode, Holger;
    • Kaderali, Lars;
    • Meyer-Bahlburg, Almut
    Publication type:
    Article
    35

    Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

    Published in:
    Cancers, 2025, v. 17, n. 1, p. 149, doi. 10.3390/cancers17010149
    By:
    • Flaadt, Tim;
    • Rehm, Jonas;
    • Simon, Thorsten;
    • Hero, Barbara;
    • Ladenstein, Ruth L.;
    • Lode, Holger N.;
    • Grabow, Desiree;
    • Nolte, Sandra;
    • Crazzolara, Roman;
    • Greil, Johann;
    • Ebinger, Martin;
    • Abele, Michael;
    • Holzer, Ursula;
    • Döring, Michaela;
    • Schulte, Johannes H.;
    • Bader, Peter;
    • Schlegel, Paul-Gerhardt;
    • Eyrich, Matthias;
    • Lang, Peter;
    • Klingebiel, Thomas
    Publication type:
    Article
    36

    Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3364, doi. 10.3390/cancers15133364
    By:
    • Lode, Holger N.;
    • Ladenstein, Ruth;
    • Troschke-Meurer, Sascha;
    • Struppe, Linda;
    • Siebert, Nikolai;
    • Zumpe, Maxi;
    • Ehlert, Karoline;
    • Huber, Stefanie;
    • Glogova, Evgenia;
    • Hundsdoerfer, Patrick;
    • Eggert, Angelika;
    • Zaniewska-Tekieli, Anna;
    • Balwierz, Walentyna;
    • Wieczorek, Aleksandra
    Publication type:
    Article
    37
    38
    39
    40
    41

    Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5751, doi. 10.3390/cancers14235751
    By:
    • Marx, Sascha;
    • Wilken, Fabian;
    • Miebach, Lea;
    • Ispirjan, Mikael;
    • Kinnen, Frederik;
    • Paul, Sebastian;
    • Bien-Möller, Sandra;
    • Freund, Eric;
    • Baldauf, Jörg;
    • Fleck, Steffen;
    • Siebert, Nikolai;
    • Lode, Holger;
    • Stahl, Andreas;
    • Rauch, Bernhard H.;
    • Singer, Stephan;
    • Ritter, Christoph;
    • Schroeder, Henry W. S.;
    • Bekeschus, Sander
    Publication type:
    Article
    42
    43
    44

    Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial.

    Published in:
    Cancers, 2018, v. 10, n. 10, p. 387, doi. 10.3390/cancers10100387
    By:
    • Siebert, Nikolai;
    • Troschke-Meurer, Sascha;
    • Marx, Madlen;
    • Zumpe, Maxi;
    • Ehlert, Karoline;
    • Gray, Juliet;
    • Garaventa, Alberto;
    • Manzitti, Carla;
    • Ash, Shifra;
    • Klingebiel, Thomas;
    • Beck, James;
    • Castel, Victoria;
    • Valteau-Couanet, Dominique;
    • Loibner, Hans;
    • Ladenstein, Ruth;
    • Lode, Holger N.
    Publication type:
    Article
    45

    Supporting the Hypothesis of Pregnancy As a Tumor: Survivin Is Upregulated in Normal Pregnant Mice and Participates in Human Trophoblast Proliferation.

    Published in:
    American Journal of Reproductive Immunology, 2008, v. 59, n. 1, p. 75, doi. 10.1111/j.1600-0897.2007.00557.x
    By:
    • Fest, Stefan;
    • Brachwitz, Nadja;
    • Schumacher, Anne;
    • Zenclussen, Maria Laura;
    • Khan, Faisal;
    • Wafula, Paul O.;
    • Casalis, Pablo A.;
    • Fill, Sara;
    • Costa, Serban-Dan;
    • Mor, Gil;
    • Volk, Hans-Dieter;
    • Lode, Holger N.;
    • Zenclussen, Ana Claudia
    Publication type:
    Article
    46
    47

    Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6196, doi. 10.3390/jcm12196196
    By:
    • Flaadt, Tim;
    • Ebinger, Martin;
    • Schreiber, Malin;
    • Ladenstein, Ruth L.;
    • Simon, Thorsten;
    • Lode, Holger N.;
    • Hero, Barbara;
    • Schuhmann, Martin U.;
    • Schäfer, Jürgen;
    • Paulsen, Frank;
    • Timmermann, Beate;
    • Eggert, Angelika;
    • Lang, Peter
    Publication type:
    Article
    48
    49
    50